Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gluten-specific CD4+ T cells are essential mediators of celiac disease pathogenesis due to their unique ability to recognize deamidated dietary antigens presented by specific MHC class II alleles. Their highly restricted antigen specificity, distinctive phenotype upon activation/exposure to gluten, key role in orchestrating both humoral autoimmunity and local inflammation make them critical targets for diagnostic assays as well as emerging therapeutic strategies focused on restoring tolerance or selectively modulating pathogenic immunity in celiac disease patients.
Immunomodulation; Tolerance induction; Selective suppression of pathogenic responses
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gluten-specific CD4+ T Cell (N/A).